MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Neuromonitoring During the Latarjet Procedure

Not Applicable

Completed

Conditions: Shoulder Instability
Iatrogenic Nerve Injury

Interventions: Device: Intra-operative neuromonitoring (XLTEK/NATUS EP Protektor)

First Posted Date: 2012-06-18

Last Posted Date: 2016-05-23

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 40

Registration Number: NCT01621126

Locations: 🇺🇸
Massachussetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Tai Chi Intervention for Chinese Americans With Depression

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: 12-week Tai Chi intervention
Behavioral: Education control group

First Posted Date: 2012-06-14

Last Posted Date: 2016-12-01

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 94

Registration Number: NCT01619631

Locations: 🇺🇸
South Cove Community Health Center, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital Depression Clinical and Research Program, Boston, Massachusetts, United States

Predictors of the Ability to Protect the Airway in Long-term Ventilated Patients

Completed

Conditions: Aspiration
Swallowing Disorder
Long Term Ventilation

Interventions: Other: Muscle Strength Measurement
Other: Ventilator

First Posted Date: 2012-06-13

Last Posted Date: 2014-10-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 30

Registration Number: NCT01618240

Locations: 🇺🇸
Massachusetts general Hospital, Boston, Massachusetts, United States

Rehabilitation With or Without Static Progressive Splinting for Wrist Stiffness

Not Applicable

Terminated

Conditions: Post-traumatic Stiff Wrists

Interventions: Procedure: Rehabilitation without splinting
Device: Joint Active Systems (JAS) Static progressive splint

First Posted Date: 2012-06-13

Last Posted Date: 2017-03-23

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 4

Registration Number: NCT01618227

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Proton Therapy Vs. IMRT for Low or Intermediate Risk Prostate Cancer

Not Applicable

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Radiation: Intensity Modulated Radiation Therapy
Radiation: Proton Beam Therapy

First Posted Date: 2012-06-12

Last Posted Date: 2024-12-09

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 454

Registration Number: NCT01617161

Locations: 🇺🇸
University of Florida Health Proton Therapy Institute, Jacksonville, Florida, United States
🇺🇸
Northwestern Medicine Chicago Proton Center, Chicago, Illinois, United States
🇺🇸
University of Maryland Medical Center, College Park, Maryland, United States

and more 10 locations

An Open-label Study to Identify Molecular Markers of Steroid Resistance

Phase 4

Terminated

Conditions: Nasal Polyps

Interventions: Drug: mometasone furoate

First Posted Date: 2012-06-11

Last Posted Date: 2018-06-12

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 11

Registration Number: NCT01616160

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Nutrition, Exercise, and Wellness Treatment (NEW Tx) for Bipolar Disorder

Phase 1

Completed

Conditions: Bipolar Disorder

Interventions: Other: Nutrition, Exercise, and Wellness (NEW) psychotherapy
Drug: Typically consists of at least one FDA-approved mood stabilizer

First Posted Date: 2012-06-08

Last Posted Date: 2018-06-07

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 38

Registration Number: NCT01615367

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder

Not Applicable

Withdrawn

Conditions: Major Depressive Disorder

Interventions: Drug: Ketamine
Drug: Scopolamine

First Posted Date: 2012-06-07

Last Posted Date: 2018-02-19

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT01613820

Locations: 🇺🇸
Depression Clinical and Reseach Program - MGH, Boston, Massachusetts, United States

Carbamylation in Renal Disease-modulation With Amino Acid Therapy

Early Phase 1

Completed

Conditions: End Stage Renal Failure on Dialysis

Interventions: Dietary Supplement: Amino acid supplementation

First Posted Date: 2012-06-05

Last Posted Date: 2016-11-10

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 23

Registration Number: NCT01612429

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma

Phase 1

Terminated

Conditions: Melanoma

Interventions: Drug: Vemurafenib
Drug: Leflunomide

First Posted Date: 2012-06-05

Last Posted Date: 2017-04-06

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 3

Registration Number: NCT01611675

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy